Furthermore, circulating omentin-1 concentrations are associated with endothelial dysfunction in patients with impaired glucose tolerance by inhibiting the NADPH oxidase activity and enhancing the TNF-induced vascular cell adhesion molecule 1 (VCAM1) expression [64,65,66]. The gene discussed is FMO5; the disease is endothelial dysfunction.